Evidence map›Paper›PMID 42668493›Full record

ArticleThe Lancet regional health. Western Pacific2026

Projected preventable cancers through full implementation of tobacco control policies in East and South-East Asian countries, 2025-2050: a modeling study.

Saeed Nemati, Marie-Pierre Nobels, Harriet Rumgay, Mojtaba Vand Rajabpour, Mattias Johansson, Mahdi Sheikh, Xiaoshuang Feng

Abstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saeed NematiEarly Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Marie-Pierre NobelsEarly Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Harriet RumgayCancer Surveillance Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Mojtaba Vand RajabpourCancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Mattias JohanssonEarly Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Mahdi SheikhEarly Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Xiaoshuang FengEarly Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To estimate the number of tobacco-related cancer cases that could be prevented if countries in East and South-East Asia achieved the highest level of implementation of the WHO MPOWER policy package (Monitor, Protect, Offer, Warn, Enforce, and Raise). Methods: Based on data from Global Health Observatory and Global Cancer Observatory. We applied fixed-effects linear regression models to examine the association between changes in the national implementation of the MPOWER policies and tobacco smoking prevalence. Population Attributable Fractions (PAFs) for 13 tobacco-related cancers were calculated using Levin's formula under the scenarios of (i) continuation of the current trend, (ii) full implementation of MPOWER. The number of preventable cases (Potential Impact Fraction-PIF) was estimated using the difference in PAFs between the two scenarios. Findings: Between 2025 and 2050, 159 million tobacco-related cancer cases were projected in East and South-East Asian countries, of which 44.2 million (PAF: 27.7%; 95% CI: 25.5-29.9) attributed to current tobacco smoking, including 41.6 million among men (PAF: 42.1%, 95% CI: 39.3-44.8) and 2.6 million among women (PAF: 4.3%, 95% CI: 3.0-5.7). Full implementation of MPOWER was estimated to prevent 3.5 million (95% CI: 2.9-4.0) cancers (PIF: 2.2%, 95% CI: 1.8-2.5). After adjusting for Human Development Index (HDI) variations, preventable cancers decreased to 2.2 million (PIF: 1.4%, 95% CI: 1.2-1.6). Interpretation: Comprehensive implementation of MPOWER policies could substantially reduce the future cancer burden in East and South-East Asian countries. Funding: None.

Indexed as

CancerPotential impact fractionPreventionTobacco control

Identifiers

PMID42668493
PMCPMC13524614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.